Schedule 13G ownership disclosure

Tracon Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 89237H100

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
900,000
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001580642-18-000851
Form type
SC 13G/A
Filer
EVENTIDE ASSET MANAGEMENT, LLC
CIK
CIK 1442891
Filed
Feb 12, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub